Literature DB >> 2008911

Urate and calcium stones--picking up a drop of mercury with one's fingers?

R L Ryall1, P K Grover, V R Marshall.   

Abstract

The evidence invariably cited to support the suspicion that urinary urate is a predisposing factor in calcium oxalate (CaOx) stone formation is critically reviewed. Analysis of the relevant literature shows that speculation is based on the clinical impression that CaOx stone-formers appear to excrete more urate than do normal subjects, and that allopurinol reduces the rate of CaOx stone recurrences. On balance, this is sufficient to suggest that a high urinary excretion of urate promotes CaOx stone formation. However, in the past, evidence to disclose the mechanism by which urate could exert this effect has been largely shrouded in confusion and controversy. The evidence for two theories that have dominated thinking in this area are reviewed and new findings are reported that indicate that neither can account for the purported effect of urate. It is concluded that dissolved urate in urine, at normal physiological pH values, directly provokes CaOx crystal nucleation by the phenomenon of salting-out. The possibility that urate promotes CaOx stone formation is further strengthened by its ability to increase significantly the amount of CaOx precipitated from solution and to cause the aggregation of individual crystals into large clusters. Future avenues of investigation that should assist in the formulation of diagnostic and therapeutic guidelines are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008911     DOI: 10.1016/s0272-6386(12)80636-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.

Authors:  David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

Review 2.  The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

3.  Monosodium urate stones are rare, and urine pH is not low in cystinuria.

Authors:  John R Asplin; Kristina Penniston; David S Goldfarb
Journal:  Am J Kidney Dis       Date:  2013-07       Impact factor: 8.860

4.  Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

Authors:  Lada Beara-Lasic; Michael H Pillinger; David S Goldfarb
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-02-09

5.  Dose-response relationship between higher serum calcium level and higher prevalence of hyperuricemia: A cross-sectional study.

Authors:  Zhichen Liu; Xiang Ding; Jing Wu; Hongyi He; Ziying Wu; Dongxing Xie; Zidan Yang; Yilun Wang; Jian Tian
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.